Home/Filings/4/0001127602-25-001184
4//SEC Filing

Chopas James George 4

Accession 0001127602-25-001184

CIK 0001492422other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:09 PM ET

Size

4.5 KB

Accession

0001127602-25-001184

Insider Transaction Report

Form 4
Period: 2025-01-13
Chopas James George
VP/Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2025-01-13$28.70/sh783$22,47437,358 total
Footnotes (1)
  • [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.

Issuer

Apellis Pharmaceuticals, Inc.

CIK 0001492422

Entity typeother

Related Parties

1
  • filerCIK 0001836430

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:09 PM ET
Size
4.5 KB